Adagio Therapeutics, Inc.

Adagio Therapeutics, Inc.verified

ADGI

Price:

$4.64

Market Cap:

$307.93M

Adagio Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of antibody-based solutions for infectious diseases in the United States. The company's lead product candidate is the ADG20 (adintrevimab), a neutralizing antibody that is in Phase 3 clinical trials for the treatment and prevention of coronavirus disease. Adagio Therapeutics, Inc. has a collaboration agreement with Adimab, LLC for the discovery and optimization of proprietary antibodies; and the Scripps Research Institute to perform research activities to identify vaccine candidates for the prevention, diagnosis or treatment of influenza or beta coronaviruses. T...[Read more]

Industry

Biotechnology

IPO Date

2021-08-06

Stock Exchange

NASDAQ

Ticker

ADGI

The Current Ratio as of December 2025 (TTM) for Adagio Therapeutics, Inc. (ADGI) is 2.47

According to Adagio Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 2.47. This represents a change of 41.90% compared to the average of 1.74 of the last 4 quarters.

Adagio Therapeutics, Inc. (ADGI) Historical Current Ratio (quarterly & annually)

How has ADGI Current Ratio performed in the past?

The mean historical Current Ratio of Adagio Therapeutics, Inc. over the last ten years is 8.01. The current 2.47 Current Ratio has changed 2.98% with respect to the historical average. Over the past ten years (40 quarters), ADGI's Current Ratio was at its highest in in the March 2023 quarter at 15.62. The Current Ratio was at its lowest in in the June 2020 quarter at 0.

Quarterly (TTM)
Annual

Average

8.01

Median

8.98

Minimum

1.62

Maximum

15.06

Adagio Therapeutics, Inc. (ADGI) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Adagio Therapeutics, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 51.53%

Maximum Annual Current Ratio = 15.06

Minimum Annual Increase = -70.30%

Minimum Annual Current Ratio = 1.62

Quarterly (TTM)
Annual
YearCurrent RatioChange
20241.62-63.67%
20234.47-70.30%
202215.0651.53%
20219.9410.67%

Adagio Therapeutics, Inc. (ADGI) Average Current Ratio

How has ADGI Current Ratio performed in the past?

The current Current Ratio of Adagio Therapeutics, Inc. (ADGI) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

7.05

5-year avg

8.01

10-year avg

8.01

Adagio Therapeutics, Inc. (ADGI) Current Ratio vs. Peers

How is ADGI’s Current Ratio compared to its peers?

Adagio Therapeutics, Inc.’s Current Ratio is less than Sage Therapeutics, Inc. (9.16), less than iTeos Therapeutics, Inc. (7.53), greater than Opthea Limited (1.57), less than AzurRx BioPharma, Inc. (2.62), less than Revance Therapeutics, Inc. (4.12), less than Concert Pharmaceuticals, Inc. (9.33), greater than Claritas Pharmaceuticals, Inc. (0.14), less than Climb Bio, Inc. (14.08), less than Pardes Biosciences, Inc. (9.81), greater than Oxurion N.V. (0.17),

Build a custom stock screener for Adagio Therapeutics, Inc. (ADGI) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Adagio Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Adagio Therapeutics, Inc. (ADGI) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Adagio Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Current Ratio?

How can you use the Current Ratio?

What is Adagio Therapeutics, Inc.'s Current Ratio?

How is the Current Ratio calculated for Adagio Therapeutics, Inc. (ADGI)?

What is the highest Current Ratio for Adagio Therapeutics, Inc. (ADGI)?

What is the 3-year average Current Ratio for Adagio Therapeutics, Inc. (ADGI)?

What is the 5-year average Current Ratio for Adagio Therapeutics, Inc. (ADGI)?

How does the current Current Ratio for Adagio Therapeutics, Inc. (ADGI) compare to its historical average?